Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.38 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.38 |
| ▸ | G6PD | P11413 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.34 |
| ▸ | FASN | P49327 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3634628 | 0.90 | CA1 (0.53) | CA1CA2TSHRKDM4EALDH1A1 | |
| SCHEMBL18934329 | 0.88 | CA1 (0.53) | CA1CA2ARTSHRG6PD | |
| SCHEMBL16940478 | 0.85 | CA1 (0.44) | CA1CA2ARTSHRCXCR2 | |
| SCHEMBL22155103 | 0.82 | TNKS (0.40) | CA1CA2TSHRMEN1KMT2A | |
| SCHEMBL13074276 | 0.81 | CA2 (0.43) | CA1CA2ARTSHRMEN1 | |
| SCHEMBL31533202 | 0.78 | ALDH1A1 (0.43) | TSHRMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL349252 | 0.78 | ALDH1A1 (0.43) | TSHRMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL29558067 | 0.78 | ALDH1A1 (0.43) | TSHRMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL18852194 | 0.77 | ALDH1A1 (0.50) | CA1CA2ARTSHRG6PD | |
| Methane SCHEMBL28982422 | 0.76 | ALDH1A1 (0.42) | MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150599-A1 | CHRYSENES FOR GREEN LUMINESCENT APPLICATIONS | E. I. Du Pont de Nemours and Company (US) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008150940-A1 | CHRYSENES FOR GREEN LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080303428-A1 | CHRYSENES FOR GREEN LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080303428-A1 | CHRYSENES FOR GREEN LUMINESCENT APPLICATIONS | CRY2, CENPE, CRY1 | CA1 2272/4885CA2 884/4885AR 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.